Stock of Interest

Posted On: July 18, 2023

Stock Report : ASTRAZEN (NSE) 17 Jul 2023

AstraZeneca Pharma India Limited (ASTRAZEN) is the operating company and covers manufacturing, sales, and marketing activities of the company in India. It is a listed company and is a subsidiary of AstraZeneca Plc, UK. It has a workforce of over 1400 employees across the country that is committed to deliver life-changing medicines to patients through innovative science and global excellence in development and commercialization. The company has an innovative portfolio in crucial areas of healthcare including cardiovascular, renal & metabolic diseases, oncology and respiratory. 

xCalData predicts ASTRAZEN will continue its Bullish phase over the next five days and trend in the range of 3718 to 3893. 

In comparison to the previous month, the price of the stock has experienced an increase of 4.03% indicating a Bullish. 

The Stock has doubled Twice since 27 Feb 2015 and took an average of 2.7 years to double. 

Majority of the technical ratios trend towards Bullish side of the spectrum.  

Collectively, xCalData suggests the stock would be in Bullish zone for next 5 days. 

The stock has not shown seasonality trend in the past. 

Reviewing the returns for the past 5 years for the same week, we see the stock has given negative returns in 2 years in the past. 

#xCalData is an exceptional app available for Android devices that offers unbiased insights into stocks, allowing investors to make informed decisions. With its user-friendly interface and comprehensive features, xCalData provides a valuable resource for anyone interested in the stock market.  Download the app from google play. 

For Actionable Intelligence, subscribe to xCalData app on Android devices: https://tinyurl.com/downloadxCalData.